The fact that the Chickenpox, Hepatitis-A and MMR vaccines were developed using aborted fetal cell lines, MRC-5 and WI-38 has never been hidden from the public. The problem is that when parents go to their family doctors for vaccinations, who asks to see the product insert? Most parents want to know the risks and possible side effects. Like their doctors, parents are mostly concerned with the health of their children. And doctors, who have been administering the vaccines for years have never checked into the ingredients, although it has always been right at their fingertips. And what would happen if they did? They would read that the vaccine contains "MRC-5", "WI-38" (or both) "human diploid cell lines".

Below are the opening paragraphs of the Manufacturer's Package Inserts for Hepatitis-A (Merck & Glaxo Smithkline) MMR and Varicella (Chickenpox) Vaccines.



Tel: 1-800-672-6372

VAQTA [Hepatitis A Vaccine, Inactivated] is an inactivated whole virus vaccine derived from hepatitis A virus (HAV) grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, purified by a combination of physical and high performance liquid chromatographic techniques developed at the Merck Research Laboratories, formalin inactivated, and then adsorbed onto aluminum hydroxide. One milliliter of the vaccine contains approximately 50 units (U) of hepatitis A virus antigen, which is purified and formulated without a preservative. Within the limits of current assay variability, the 5OU dose of VAQTA contains less than 0.1 mcg of non-viral protein, less than 4 x 10 mcg of DNA, less than 10 rncg of bovine albumin, and less than 0.8 mcg of formaldehyde. Other process chemical residuals are less than 10 parts per billion (ppb).

VAQTA [Hepatitis A Vaccine, Inactivated] is an inactivated whole virus vaccine derived from hepatitis A virus (HAV) grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, purified by a combination of physical and high performance liquid chromatographic techniques developed at the Merck Research Laboratories, formalin inactivated, and then adsorbed onto aluminum hydroxide. One milliliter of the vaccine contains approximately 50 units (U) of hepatitis A virus antigen, which is purified and formulated without a preservative. Within the limits of current assay variability, the 5OU dose of VAQTA contains less than 0.1 mcg of non-viral protein, less than 4 x 10 mcg of DNA, less than 10 rncg of bovine albumin, and less than 0.8 mcg of formaldehyde. Other process chemical residuals are less than 10 parts per billion (ppb).

SmithKline Beecham Pharmaceuticals
1-800-633-8900 ext. 5231

DESCRIPTION PRESCRIBING INFORMATION (PACKAGE INSERT) Hepatitis A Vaccine, Inactivated Havrix

Havrix (Hepatitis A Vaccine, Inactivated) is a noninfectious hepatitis A vaccine developed and manufactured by SmithKline Beecham Biologicals. (The virus (strain HM175) is propagated in MRC5 human diploid cells.) After removal of the cell culture medium, the cells are lysed to form a suspension. This suspension is purified through ultrafiltration and gel permeation chromatography procedures. Treatment of this lysate with formalin ensures viral inactivation.

Havrix contains a sterile suspension of inactivated virus; viral antigen activity is referenced to a standard using an enzyme linked immunosorbent assay (ELISA), and is therefore expressed in terms of ELISA Units (EL.U.).

Havrix is supplied as a sterile suspension for intramuscular administration. The vaccine is ready for use without reconstitution; it must be shaken before administration to assure a uniform suspension. After shaking, the vaccine is a homogeneous white turbid suspension. Each 1 mL adult dose of vaccine consists of not less than 1440 EL.U. of viral antigen, adsorbed on 0.5 mg of aluminum, as aluminum hydroxide. There are two pediatric dose formulations, each with its own dosing schedule (see DOSAGE AND ADMINISTRATION).

The formulations are: not less than 360 EL.U. of viral antigen/0.5 mL; not less than 720 EL.U. of viral antigen/0.5 mL. Each dose is adsorbed onto 0.25 mg of aluminum, as aluminum hydroxide.

The vaccine preparations also contain 0.5% (w/v) of 2-phenoxyethanol as a preservative. Other excipients are: amino acid supplement (0.3% w/v) in a phosphate-buffered saline solution and polysorbate 20 (0.05 mg/mL). Residual MRC5 cellular proteins (not more than 5 mcg/adult dose) and traces of formalin (not more than 0.1 mg/mL) are present.

Tel: 1-800-672-6372

M-M-R II (MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE)

DESCRIPTION

M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live) is a live virus vaccine for vaccination against measles (rubeola), mumps and rubella (German measles). M-M-R II is a sterile lyophilized preparation of (1) ATTENUVAX' (Measles Virus Vaccine Live), a more attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture; (2) MUMPSVAX* (Mumps Virus Vaccine Live), the Jerl Lynn (B level) strain of mumps virus propagated in chick embryo cell culture; and (3) MERUVAX'll (Rubella Virus Vaccine Live), the Wistar RA 27/3 strain of live attenuated rubella virus propagated in WI-38 human diploid lung fibroblasts.

The growth medium for measles and mumps is Medium 199 (a buffered salt solution containing vitamins and amino acids and supplemented with fetal bovine serum) containing SPGA (sucrose, phosphate, glutamate, and human albumin) as stabilizer and neomycin.

The growth medium for rubella is Minimum Essential Medium (MEM) [a buffered salt solution containing vitamins and amino acids and supplemented with fetal bovine serum] containing human serum albumin and neornycin. Sorbitol and hydrolyzed gelatin stabilizer are added to the individual virus harvests.

The cells, virus pools, fetal bovine serum, and human albumin are all screened for the absence of adventitious agents. Human albumin is processed using the Cohn cold ethanol fractionation procedure.

The reconstituted vaccine is for subcutaneous administration. Each 0.5 mL dose contains not less than 1,000 TCID(tissue culture infectious doses) of measles virus; 20,000 TCID of mumps virus; and 1,000 TCID of rubella virus. Each dose of the vaccine is calculated to contain sorbitol (14.5 mg), sodium phosphate, sucrose (1.9 mg), sodium chloride, hydrolyzed gelatin (14.5 mg), human albumin (0.3 mg), fetal bovine serum (<l ppm), other buffer and media ingredients and approximately 25 mcg of neomycin. The product contains no preservative.

VARIVAX

[Varicella Virus Vaccine Live (Oka/Merck)]

DESCRIPTION

VARIVAX [Varicella Virus Vaccine Live (Oka/Merck)] is a preparation of the Oka/Merck strain of live, attenuated varicella virus. The virus was initially obtained from a child with natural varicella, then introduced into human embryonic lung cell cultures, adapted to and propagated in embryonic guinea pig cell cultures and finally propagated in human diploid cell cultures (WI-38). Further passage of the virus for varicella vaccine was performed at Merck Research Laboratories (MRL) in human diploid cell cultures (MRC-5) that were free of adventitious agents. This live, attenuated varicella vaccine is a lyophilized preparation containing sucrose, phosphate, glutamate, and processed gelatin as stabilizers.

VARIVAX, when reconstituted as directed, is a sterile preparation for subcutaneous administration. Each 0.5 mL dose contains the following: a minimum of 1350 PFU (plaque forming units) of Oka/Merck varicella virus when reconstituted and stored at room temperature for 30 minutes, approximately 25 mg of sucrose, 12.5 mg hydrolyzed gelatin, 3.2 mg sodium chloride, 0.5 mg monosodium L-glutamate, 0.45 mg of sodium phosphate dibasic, 0.08 mg of potassium phosphate monobasic, 0.08 mg of potassium chloride; residual components of MRC-5 cells including DNA and protein; and trace quantities of sodium phosphate monobasic, EDTA, neomycin, and fetal bovine serum. The product contains no preservative. But that statement alone does not mean "aborted fetal tissue". Diploid cells are defined as "having twice the number of chromosomes normally occurring in a mature germ cell". Deceptive footwork on the part of the pharmaceutical companies; legal, without disclosing what would have surely led to a public outcry and a demand for immediate change.

Next, most doctors have at their disposal a book called a PDR (Physician's Desk Reference). The same information, listing the WI-38 and MRC-5 cell lines can be found there as well.

But what happens when the information still does not prove that MRC-5 or WI-38 are aborted fetal cell lines? There are several references to document this as well a few of which are listed below. But finding the resource material yourself can be time consuming and cumbersome. Taken from the Coriell Cell Repository, a company that actually sells fetal (and other) tissue cell lines, is a complete scientific description of the cell lines and the information on the original abortions:

AG05965

Fibroblast

Homo sapiens

proband

$75

References.

Borsi L, Balza E, Gaggero B, Allemanni G, Zardi L, J Biol
Chem 270:6243-5 (1995) The alternative splicing pattern of the tenascin-C pre-mRNA is controlled by the extracellular pH. PubMed ID: 7534307

Futreal PA, Cochran C, Marks JR, Iglehart JD, Zimmerman
W, Barrett JC, Wiseman RW, Cancer Res 54:1791-4 (1994)
Mutation analysis of the THRA1 gene in breast cancer:
deletion/fusion of the gene to a novel sequence on 17q
in the BT474 cell line. PubMed ID: 7511052

Kilfeather SA, Collins D, McCormack P, Cotter T, O'Malley K,
Mech Ageing Dev 63:247-56 (1992) The effect of in
vitro aging on human lung fibroblast beta-adrenergic receptor density, coupling and response. PubMed ID: 1319530

Jacobs, Nature 277:168 (1970), Characteristics of a human
diploid cell designated MRC-5.

Cell Line Characteristics

Read one of the letters Merck has written

Please Click on the image to enlarge

Though the First Plumbline Apologetics dose not accept the Roman Catholic Church teachings or other wise this is a letter that the Children of God for Life a Catholic Charity against Abortion reported.

The vaccine will be manufactured using Crucell’s PER C6 cell line, which is derived from the retinal tissue of an 18 week gestation fetus, aborted because, according to Dr. Van Der Eb at a recent hearing with the FDA, “The women wanted to get rid of the fetus. …The father was not known and that was, in fact, the reason why the abortion was requested.”

In the FDA report found at http://www.fda.gov/ohrms/dockets/ac/01/transcripts/
3750t1_01.pdf

Children of God for Life has fought this issue before. Last fall when the Federal Government awarded a contract to Acambis for the production of a new smallpox vaccine using the aborted fetal cell line MRC-5, a massive public protest quickly mounted. Thousands of letters poured into the offices of the CDC, FDA, HHS and the pharmaceutical companies involved in the bid process, demanding alternatives. Thirty days later, a second contract was awarded to Acambis Baxter for 155 million more doses – but this time, they will use Vero cells, not MRC-5.

“When are the pharmaceutical companies and our government going to wake up and realize this is not the direction our country needs to take in developing important medical treatments and vaccines?”, Children of God for Life’s Executive Director Debi Vinnedge stated. “We already have an existing campaign and petition against vaccines utilizing aborted fetal tissue – MMR, Chickenpox and Hepatitis-A and so many parents are refusing to use these vaccines as they learn the truth about their source. They have a right to protect the health and safety of their families without violating their religious beliefs or contributing to the culture of death in this country.”

The non-profit, pro-life organization has already received over 450,000 signatures in their Campaign for Ethical Vaccines. Vinnedge admits the current situation is frightening because although many people would consider the dangers of something like chickenpox to be nominal, smallpox and ebola are well known to be deadly.

“When an on-line poll was conducted by WorldNet Daily News on whether people would use a smallpox vaccine derived from aborted fetal tissue, 56% of the people said they would refuse it, 34% said it would not deter them and another 10% were undecided. The public has a right to expect our government to take the necessary measures to ensure that the entire population can be protected against deadly, infectious disease – not just those who see nothing wrong with profiting from abortion.”

The revelation of the PER C6 cell line which was developed in the Netherlands also turned up a number of new alliances formed with American pharmaceuticals and Crucell. Under Phase 2 Clinical Trials is a new HIV vaccine being developed by Merck which will also use the PER C6 cell line.

“What do these people at Merck think?” Vinnedge wants to know. “Do they think that people with HIV are somehow less sensitive to abortion than the general public? Clearly they simply do not care about anyone or anything other than their bottom line! We are ready to support any company who promises to do it better – and we can guarantee them a solid return on their investment!”

Vinnedge is asking the public to respond once again by writing formal letters of protest to Tommy Thompson at the Department of Health and Human Services as well as the Centers for Disease Control and Merck. Any email correspondence to these offices should be carbon copied to ebola@cogforlife.org as the organization will track the public response. Addresses are as follows:

The Honorable Tommy Thompson
Department of Health & Human Services
200 Independence Avenue, S.W. Room 615-F
Washington, D.C. 20201

EMAIL: hhsmail@os.dhhs.gov

Centers for Disease Control
1600 Clifton Road NE Mail Stop D66
Atlanta, GA 30333
USA

Website: http://www.cdc.gov/netinfo.htm


Isabelle Claxton, Executive Director Public Affairs

Merck Vaccine Division

770 Sumneytown Pike P.O. Box 4

Westpoint, PA 19486

Subject: Pro-life Groups Work to Have Merck Pharmaceuticals Reconsider Abortion-Tainted Vaccines

Pro-life Groups Work to Have Merck Pharmaceuticals Reconsider Abortion-Tainted Vaccines

27 babies deliberately aborted in controlled setting in order to extract live virus

http://www.lifesite.net/ldn/2004/may/04050304.html


NORTH BRANCH, NJ, May 3, 2004 (LifeSiteNews.com) - Human Life International and Children of God for Life joined forces as a Merck Shareholder Meeting last month winning enough votes to have their pro-life resolution considered.

"As stockholders in Merck we are particularly distressed at the violation of human rights that occurred in the early 1960s in the development of two cell lines, the RA 27/3 and the WI-38, which were used to create the MMR vaccine. We are even more distressed that this same pattern of human rights violations continues to take place with the PER-C6 cell line that Merck has taken license for in developing a new AIDS vaccine", said HLI's Fr. Euteneuer in his opening statements at the annual Merck Shareholder meeting on April 27th in North Branch, NJ.

He continued a relentless pounding of Merck's unethical behavior by admonishing the board, "The RA 27/3 obtained its tissue from the last in a line of 27 babies who were deliberately aborted in a controlled setting in order to extract the live virus. These cell lines were thus created at the cost of dozens of innocent human lives with the full knowledge of Merck researchers."

The room fell silent as Fr. Euteneuer concluded, "We ask Merck for two things: full disclosure about the nature of Merck's involvement in this gruesome business, and the withdrawal of the unethical vaccine from the market as soon as possible."

Debbie Vinnedge of Children of God for Life who surprised the fidgeting board members by stating, "On behalf of over half a million parents and medical professionals nationwide who have joined our Campaign for Ethical Vaccines, I would like to begin by thanking you Mr. Gilmartin and the members of the Board for bringing your ethically produced single dose measles and mumps vaccines back to the market last summer."

While the chairman of the meeting ignored the pro-lifers several shareholders told the meeting they were shocked by the revelations and demanded action. At the end of the meeting the pro-lifers had more than the necessary votes to continue to pursue the pro-life resolution.

Despite the victory, perhaps one of the most troubling aspects about the shareholder meeting came from the company's own admission that they had partnered with the Bill Gates Foundation, one of the larger supporters of Planned Parenthood worldwide, in order to fight the HIV epidemic in Africa. Merck intends to use the aborted fetal cell line PER C6 to develop its new HIV vaccine.

Read HLI's Full Statementt:

http://hli.org/merck_merck_meeting2004.html

Read Children of God for Life's Statement

http://www.cogforlife.org/merck2004boardstatement.htm

(c) Copyright: LifeSite Daily News is a production of Interim Publishing. Permission to republish is granted (with limitation*) but acknowledgement of source is *REQUIRED* (use LifeSiteNews.com).

NEWS TIPS to lsn@lifesite.net or call 1-866-787-9947 or (416) 204-1687 ext.444

Please help us to continue this service. Mail contributions to: Interim Publishing, Att'n LifeSite, 104 Bond St. E., Toronto, ON M5B 1X9 or contribute on line at

http://www.lifesite.net/contribute/lifesite/

The following vaccination schedule is the current recommendation as of July 2004.

What you may not know is that the MMR [Measles, Mumps, Rubella] Vaccine and the Varicella [chickenpox] vaccines are both propagated [grown] on tissue derived from aborted babies. The cells are called "human diploid cells" in the product description [pdf of MMR product description | pdf of Varicella product description]

There are options. First of all, only two of the recommended vaccines use aborted babies [the MMR and the varicella vaccine]. If you would like to have your child protected, consider the following:

Measles:

Merck & Co. has a measles only vaccine available that does not use aborted babies. The name is AttenuVax and can be ordered by your physician from Merck in a pack of 10 single use vials by calling 1-800-637-2579. The catalogue number for the AttenuVax is 458900. The AttenuVax would be administered at the normal times recommended for the MMR.

Mumps:

Merck & Co. also produces a mumps vaccine that does not use aborted babies. The name is MumpsVax and can be ordered by your physician from Merck in a pack of 10 single use vials by calling 1-800-637-2579. The catalogue number is 458400. There is an error at several websites that state that this product is made with aborted babies. This is not true and the product information for AttenuVax and MumpsVax can be downloaded here: Measles/Mumps Vaccine Product information: word | pdf

Rubella:

There is no currently available vaccine against rubella that is not propagated on human diploid cells [aborted babies].

Rubella is a mild childhood disease that is primarily vaccinated for due to the Congenital Rubella Syndrome [CRS]. CRS causes birth defects in babies of mothers who become infected during their first trimester. Approximately 25% of infected mothers will have a baby with some congenital abnormality.
The World Health Organization has recommended one of two ways to prevent CRS:

"For countries wishing to prevent the occurrence of congenital rubella infection including CRS, two approaches are recommended:

1) prevention of CRS only, through immunization of adolescent girls and/or women of childbearing age; or

2) elimination of rubella as well as CRS through universal vaccination of infants, surveillance and assuring immunity in women of childbearing age."
Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs. Geneva, 12-14 January 2000

This means that prevention of CRS can be done with a single vaccination done at least one month prior to conception.

Male children could permanently forego the vaccination according to the first strategy outlined by the WHO. Female children could wait until they are of childbearing age. At that time, a Rubella IgG blood antibody level could be drawn because she may have contracted a sub-clinical/mild case of rubella in childhood and have antibodies and never need the vaccination. Hopefully by that time there will be a commercially available rubella vaccine that does not use human fetal tissue. At the time of this writing, the author has learned that the rubella vaccine available in China does use human fetal tissue, and several rubella vaccines are available in Japan and I am unaware of the cell medium used for these vaccines. We will keep you up to date.

Varicella [chickenpox]:

There is no currently available chickenpox vaccine that does not use human diploid cells [aborted babies] to propagate the cells. The varicella vaccine is recommended by the CDC, but due to origin of the vaccine, there is a need for a varicella vaccine that is not derived from aborted babies.

What you can do:

We recommend that you let your doctor know that you don't want vaccines made from aborted babies. Call Merck & Co. [1-800-MERCK-Rx] and tell them that you would like a varicella and rubella vaccine that isn't propagated on human diploid cells or MRC-5 and WI-38. Call and write your Senators and Representative to discuss this issue with them. Finally, live by your convictions. Of what benefit are convictions if one is not willing to live by them? It is possible to properly protect your children from serious childhood illnesses and at the same time not promote abortion by using products made from aborted babies.